Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-07-19

Clinical Trial Update: Adverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy Patients

View source ↗

Summary

A European physician survey (aEscape) evaluated an adverse event scale used in epilepsy patients. The study was sponsored by UCB Pharma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Not specified

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy | Status: COMPLETED